HealthStream Unveils Innovations for Privileging, Credentialing, and Data Management
HealthStream (Nasdaq: HSTM), a top healthcare technology platform for workforce solutions, showcased several innovations for CredentialStream® at the NAMSS 2024 Conference. CredentialStream is an industry-leading credentialing solution for healthcare organizations and is continually enhancing its capabilities to maintain its market…
MATTER Unveils First Paratus Digital Health Hub Accelerator in BARDA Network
MATTER, a leading healthcare incubator and innovation hub, has launched the inaugural accelerator program for the Paratus Digital Health Hub. Paratus is part of the Biomedical Advanced Research and Development Authority (BARDA), which operates under the U.S. Department of Health…
Henry Schein Launches Customer Assistance Hotline for Hurricane Helene
Henry Schein, Inc. (Nasdaq: HSIC) is reminding customers in Florida and areas expected to be impacted by Hurricane Helene that its Customer Assistance Hotline is available for dentists and physicians facing operational, logistical, or financial challenges due to the storm.…
Henry Schein Launches ‘Prepare to Care’ Program to Enhance Emergency Preparedness
Henry Schein, Inc. (Nasdaq: HSIC), the leading provider of health care solutions for dental and medical practitioners, has unveiled the “Prepare to Care” initiative through the Henry Schein Cares Foundation, Inc. (HSCF). This program aims to enhance emergency preparedness and…
Explore Henry Schein’s Digital Solutions and Financing Options at DS World
Henry Schein, Inc. (Nasdaq: HSIC) is set to make a splash at DS World with its educational FastPass session titled “Thrive at DS World with Henry Schein.” This session, designed for dental professionals, will take place at Caesars Forum in…
Baxter Unveils Next-Gen THE VEST for Airway Clearance
Baxter International Inc. (NYSE:BAX), a global leader in medical technology, has launched its next-generation airway clearance system, the Vest Advanced Pulmonary Experience (APX) System, at the North American Cystic Fibrosis Conference. This innovative system is designed to support daily therapy…
Superior HealthPlan Introduces Assessment Tool to Connect Texans with Community Support
Superior HealthPlan, a prominent managed care organization in Texas and part of Centene Corporation (NYSE: CNC), has launched a new screening tool designed to help Texans access community resources more easily. This assessment focuses on non-medical drivers of health—barriers that…
Centene’s Health Net Awarded California Medicaid Dental Contract for LA and Sacramento
Centene Corporation (NYSE: CNC), a prominent healthcare enterprise dedicated to enhancing health outcomes, announced that its subsidiary, Health Net Community Solutions, has been chosen by the California Department of Health Care Services to provide managed dental care services to Medi-Cal…
Varian Partners with Ballad Health for 10-Year Oncology Initiative in Rural Areas
Varian, a Siemens Healthineers company, has announced a 10-year agreement with Ballad Health to enhance oncology treatment services for patients in rural communities across the Appalachian Highlands, including Northeast Tennessee, Southwest Virginia, northwestern North Carolina, and southeastern Kentucky. This transformative…
HCA Healthcare Unveils 2024 Awards of Distinction
HCA Healthcare, Inc. (NYSE:HCA), a leading healthcare provider in the nation, presented its annual HCA Healthcare Awards of Distinction during a ceremony in Nashville, Tennessee. These awards, including the Frist Humanitarian Award, the HCA Healthcare Innovators Award, and the HCA…
CVS Health® Prepares to Support Customers and Colleagues as Hurricane Helene Approaches
CVS Health® (NYSE: CVS) is proactively preparing for the impending landfall of Hurricane Helene in Florida. The company prioritizes the health and safety of its customers, members, and employees, aiming to provide communities with essential products and services ahead of…
Estrella Immunopharma’s ARTEMIS® T-Cell Therapy Leads to Complete Remission in First Patient
Estrella Immunopharma, Inc. (Nasdaq: ESLA, ESLAW), a clinical-stage biopharmaceutical company specializing in ARTEMIS® T-cell therapies targeting CD19 and CD22 for cancer and autoimmune disease treatment, has announced that the first patient in the Phase I/II STARLIGHT-1 clinical trial achieved complete…